GAMIFANT
- Product NDC
- 66658-522
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- emapalumab-lzsg
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- Swedish Orphan Biovitrum AB (publ)
- Application
- BLA761107
- Marketing category
- BLA
- Substance
- EMAPALUMAB
- Current FDA listing
- Yes
Packages
| Package NDC | Description | Marketing start | Marketing end | Sample | Status |
|---|
| 66658-522-01 | 1 VIAL, SINGLE-USE in 1 CARTON (66658-522-01) / 2 mL in 1 VIAL, SINGLE-USE | 2023-06-07 | | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| GAMIFANT | Swedish Orphan Biovitrum AB (publ) | 2026-03-26 | HUMAN PRESCRIPTION DRUG LABEL | 10 |